Overview

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving high dose chemotherapy and total body irradiation before and repeating high dose chemotherapy after a bone marrow transplant could reduce the incidence of graft rejection and disease for patients with blood cancers
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators:
National Center for Research Resources (NCRR)
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Busulfan
Cyclophosphamide